341 related articles for article (PubMed ID: 29400011)
21. Endometriosis-associated ovarian cancer: a different clinical entity.
Leone Roberti Maggiore U; Bogani G; Paolini B; Martinelli F; Chiarello G; Spanò Bascio L; Chiappa V; Ferrero S; Ditto A; Raspagliesi F
Int J Gynecol Cancer; 2024 Jun; 34(6):863-870. PubMed ID: 38531540
[TBL] [Abstract][Full Text] [Related]
22. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
23. Comparative study of ovarian clear cell carcinoma with and without endometriosis in People's Republic of China.
Ye S; Yang J; You Y; Cao D; Bai H; Lang J; Chen J; Shen K
Fertil Steril; 2014 Dec; 102(6):1656-62. PubMed ID: 25256925
[TBL] [Abstract][Full Text] [Related]
24. Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynecol Cancer; 2018 Jan; 28(1):11-18. PubMed ID: 28930811
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis.
Barreta A; Sarian LO; Ferracini AC; Costa LBE; Mazzola PG; de Angelo Andrade L; Derchain S
Hum Pathol; 2019 Mar; 85():72-81. PubMed ID: 30447298
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of endometriosis in epithelial ovarian cancer. Analysis of the associated clinical features and study on molecular mechanisms involved in the possible causality.
Machado-Linde F; Sánchez-Ferrer ML; Cascales P; Torroba A; Orozco R; Silva Sánchez Y; Nieto A; Fiol G
Eur J Gynaecol Oncol; 2015; 36(1):21-4. PubMed ID: 25872329
[TBL] [Abstract][Full Text] [Related]
27. Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics.
Li Q; Sun Y; Zhang X; Wang L; Wu W; Wu M; Meng C; Liu G
Cancer Biol Ther; 2019; 20(7):1029-1034. PubMed ID: 30913953
[No Abstract] [Full Text] [Related]
28. Endometrioid adenocarcinoma of the ovary and endometriosis.
Valenzuela P; Ramos P; Redondo S; Cabrera Y; Alvarez I; Ruiz A
Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):83-6. PubMed ID: 16844279
[TBL] [Abstract][Full Text] [Related]
29. Prognostic implication of endometriosis in clear cell carcinoma of the ovary.
Orezzoli JP; Russell AH; Oliva E; Del Carmen MG; Eichhorn J; Fuller AF
Gynecol Oncol; 2008 Sep; 110(3):336-44. PubMed ID: 18639330
[TBL] [Abstract][Full Text] [Related]
30. Malignant transformation of ovarian endometriosis.
Nishida M; Watanabe K; Sato N; Ichikawa Y
Gynecol Obstet Invest; 2000; 50 Suppl 1():18-25. PubMed ID: 11093057
[TBL] [Abstract][Full Text] [Related]
31. Endometrioid Carcinoma of the Ovary: Outcomes Compared to Serous Carcinoma After 10 Years of Follow-Up.
Bouchard-Fortier G; Panzarella T; Rosen B; Chapman W; Gien LT
J Obstet Gynaecol Can; 2017 Jan; 39(1):34-41. PubMed ID: 28062021
[TBL] [Abstract][Full Text] [Related]
32. Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study.
Zhou L; Yao L; Dai L; Zhu H; Ye X; Wang S; Cheng H; Ma R; Liu H; Cui H; Chang X
J Ovarian Res; 2021 May; 14(1):63. PubMed ID: 33941230
[TBL] [Abstract][Full Text] [Related]
33. Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis.
McMeekin DS; Burger RA; Manetta A; DiSaia P; Berman ML
Gynecol Oncol; 1995 Oct; 59(1):81-6. PubMed ID: 7557621
[TBL] [Abstract][Full Text] [Related]
34. Demographic, Clinical, and Prognostic Factors of Ovarian Clear Cell Adenocarcinomas According to Endometriosis Status.
Schnack TH; Høgdall E; Thomsen LN; Høgdall C
Int J Gynecol Cancer; 2017 Nov; 27(9):1804-1812. PubMed ID: 28976447
[TBL] [Abstract][Full Text] [Related]
35. Prognostic analysis of ovarian cancer associated with endometriosis.
Kumar S; Munkarah A; Arabi H; Bandyopadhyay S; Semaan A; Hayek K; Garg G; Morris R; Ali-Fehmi R
Am J Obstet Gynecol; 2011 Jan; 204(1):63.e1-7. PubMed ID: 21074136
[TBL] [Abstract][Full Text] [Related]
36. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases.
Veras E; Mao TL; Ayhan A; Ueda S; Lai H; Hayran M; Shih IeM; Kurman RJ
Am J Surg Pathol; 2009 Jun; 33(6):844-53. PubMed ID: 19342944
[TBL] [Abstract][Full Text] [Related]
37. Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute.
Zhao T; Shao Y; Liu Y; Wang X; Guan L; Lu Y
J Ovarian Res; 2018 Jun; 11(1):53. PubMed ID: 29941051
[TBL] [Abstract][Full Text] [Related]
38. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
39. Long term survival of ovarian endometriosis associated clear cell and endometrioid ovarian cancers.
Noli S; Cipriani S; Scarfone G; Villa A; Grossi E; Monti E; Vercellini P; Parazzini F
Int J Gynecol Cancer; 2013 Feb; 23(2):244-8. PubMed ID: 23314280
[TBL] [Abstract][Full Text] [Related]
40. Primary debulking surgery versus neo-adjuvant chemotherapy in stage III/IV ovarian cancer: Comparison of perioperative morbidity and survival data in Pakistani women.
Chishti U; Aziz AB
J Pak Med Assoc; 2015 Mar; 65(3):306-9. PubMed ID: 25933567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
